Temozolomide and Chronic obstructive pulmonary disease - a phase IV clinical study of FDA data

Summary:

Chronic obstructive pulmonary disease is reported as a side effect among people who take Temozolomide (temozolomide), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months also take Acetylcysteine, and have Gliosarcoma.

The phase IV clinical study analyzes which people have Chronic obstructive pulmonary disease when taking Temozolomide. It is created by eHealthMe based on reports of 16,598 people who have side effects when taking Temozolomide from the FDA, and is updated regularly.

What is Temozolomide?

Temozolomide has active ingredients of temozolomide. It is often used in glioblastoma multiforme. eHealthMe is studying from 16,644 Temozolomide users. Check the latest studies of Temozolomide.

What is Chronic obstructive pulmonary disease?

Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe) is found to be associated with 1,807 drugs and 2,206 conditions by eHealthMe. Check the latest studies of Chronic obstructive pulmonary disease.

On Jul, 19, 2026

16,598 people reported to have side effects when taking Temozolomide.
Among them, 15 people (0.09%) have Chronic obstructive pulmonary disease.

Could Temozolomide cause Chronic obstructive pulmonary disease?

Among these 15 people:

How long have people been on Temozolomide when they have Chronic obstructive pulmonary disease? *

What is the gender of people who have Chronic obstructive pulmonary disease when taking Temozolomide? *

female: 21.43 %
male: 78.57 %

What is the age of people who have Chronic obstructive pulmonary disease when taking Temozolomide? *

What are other drugs people take besides Temozolomide? *

Foradil: 2 people, 13.33%
Dexamethasone: 2 people, 13.33%
Acetylcysteine: 2 people, 13.33%
Prilosec: 1 person, 6.67%
Lamictal: 1 person, 6.67%
Klonopin: 1 person, 6.67%
Fosamax: 1 person, 6.67%
Forteo: 1 person, 6.67%
Seroquel Xr: 1 person, 6.67%
Dexamethasone Sodium Phosphate: 1 person, 6.67%

What are other side effects people have besides Chronic obstructive pulmonary disease? *

Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 6 people, 40.00%
Dehydration (dryness resulting from the removal of water): 3 people, 20.00%
Sputum Culture Positive: 3 people, 20.00%
Oedema Peripheral (superficial swelling): 3 people, 20.00%
Swallowing Difficulty: 3 people, 20.00%
Cardiac Failure Congestive: 2 people, 13.33%
Pain: 2 people, 13.33%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 13.33%
Mitral Valve Incompetence (inefficient heart valve): 2 people, 13.33%
Weakness: 2 people, 13.33%

What are the existing conditions these people have? *

Gliosarcoma (a cancer of the brain that comes from glial, or supportive, brain cells): 3 people, 20.00%
Stress And Anxiety: 1 person, 6.67%
Ovarian Cancer (cancer of ovary): 1 person, 6.67%
Osteoporosis (bones weak and more likely to break): 1 person, 6.67%
Neoplasm Recurrence (reoccurrence of tumour): 1 person, 6.67%
Depression: 1 person, 6.67%
Bipolar Disorder (mood disorder): 1 person, 6.67%
Affective Disorder (mental disorder): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Temozolomide and have Chronic obstructive pulmonary disease?

- Check whether Chronic obstructive pulmonary disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Temozolomide:

Temozolomide (16,644 reports)

Browse all side effects of Temozolomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Chronic obstructive pulmonary disease:

Chronic obstructive pulmonary disease (1,807 drugs)

Browse all the conditions that are associated with Chronic obstructive pulmonary disease:

Chronic obstructive pulmonary disease (2,206 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on temozolomide (the active ingredients of Temozolomide) and Temozolomide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.